Skip to main content

MoneyWorks4Me

Granules India informs about press release

21 Jan 2016 Evaluate

Granules India has informed about a press release dated January 21, 2016, titled ‘Granules USA, the wholly owned subsidiary of Granules India, entered into an agreement with Par Pharmaceutical Inc. to market generic version of omeprazole and sodium bicarbonate’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1778.25
Dr. Reddys Labs. 1350.20
Cipla 1380.00
Lupin 2009.00
Zydus Lifesciences 1244.00
View more..